{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T04:04:54Z","timestamp":1792814694611,"version":"4.5.0"},"reference-count":115,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Netherlands Cardiovascular Research Initiative"},{"DOI":"10.13039\/501100002996","name":"Dutch Heart Foundation","doi-asserted-by":"publisher","award":["CVON2014-02"],"award-info":[{"award-number":["CVON2014-02"]}],"id":[{"id":"10.13039\/501100002996","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003246","name":"NWO","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003246","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003246","name":"Netherlands Organisation for Scientific Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003246","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimie"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/j.biochi.2016.12.019","type":"journal-article","created":{"date-parts":[[2017,1,7]],"date-time":"2017-01-07T20:45:19Z","timestamp":1483821919000},"page":"75-84","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":381,"special_numbering":"C","title":["The role and regulation of the peroxisome proliferator activated receptor alpha in human liver"],"prefix":"10.1016","volume":"136","author":[{"given":"Sander","family":"Kersten","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rinke","family":"Stienstra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biochi.2016.12.019_bib1","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1152\/physrev.00025.2005","article-title":"Transcriptional regulation of metabolism","volume":"86","author":"Desvergne","year":"2006","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.biochi.2016.12.019_bib2","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/nrendo.2016.135","article-title":"PPARs in obesity-induced T2DM, dyslipidaemia and NAFLD","volume":"13","author":"Gross","year":"2017","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.biochi.2016.12.019_bib3","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.bbadis.2011.02.014","article-title":"PPARs are a unique set of fatty acid regulated transcription factors controlling both lipid metabolism and inflammation","volume":"1812","author":"Varga","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.biochi.2016.12.019_bib4","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/0092-8674(95)90199-X","article-title":"The nuclear receptor superfamily: the second decade","volume":"83","author":"Mangelsdorf","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.biochi.2016.12.019_bib5","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1128\/MCB.06175-11","article-title":"Genome-wide profiling of liver X receptor, retinoid X receptor, and peroxisome proliferator-activated receptor alpha in mouse liver reveals extensive sharing of binding sites","volume":"32","author":"Boergesen","year":"2012","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.biochi.2016.12.019_bib6","doi-asserted-by":"crossref","first-page":"10539","DOI":"10.1093\/nar\/gkw742","article-title":"Chromatin recruitment of activated AMPK drives fasting response genes co-controlled by GR and PPARalpha","volume":"44","author":"Ratman","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.biochi.2016.12.019_bib7","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.1093\/nar\/gkq012","article-title":"Profiling of promoter occupancy by PPARalpha in human hepatoma cells via ChIP-chip analysis","volume":"38","author":"van der Meer","year":"2010","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.biochi.2016.12.019_bib8","first-page":"649","article-title":"Peroxisome proliferator-activated receptors: nuclear control of metabolism","volume":"20","author":"Desvergne","year":"1999","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.biochi.2016.12.019_bib9","doi-asserted-by":"crossref","first-page":"127","DOI":"10.3945\/an.111.001602","article-title":"Mechanisms of gene regulation by fatty acids","volume":"3","author":"Georgiadi","year":"2012","journal-title":"Adv. Nutr."},{"key":"10.1016\/j.biochi.2016.12.019_bib10","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.cell.2006.06.049","article-title":"Anatomical profiling of nuclear receptor expression reveals a hierarchical transcriptional network","volume":"126","author":"Bookout","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.biochi.2016.12.019_bib11","doi-asserted-by":"crossref","first-page":"4195","DOI":"10.1210\/endo.142.10.8458","article-title":"Rat PPARs: quantitative analysis in adult rat tissues and regulation in fasting and refeeding","volume":"142","author":"Escher","year":"2001","journal-title":"Endocrinology"},{"key":"10.1016\/j.biochi.2016.12.019_bib12","doi-asserted-by":"crossref","first-page":"28918","DOI":"10.1074\/jbc.M910350199","article-title":"Defect in peroxisome proliferator-activated receptor alpha-inducible fatty acid oxidation determines the severity of hepatic steatosis in response to fasting","volume":"275","author":"Hashimoto","year":"2000","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.biochi.2016.12.019_bib13","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1172\/JCI6223","article-title":"Peroxisome proliferator-activated receptor alpha mediates the adaptive response to fasting","volume":"103","author":"Kersten","year":"1999","journal-title":"J.\u00a0Clin. Investig."},{"key":"10.1016\/j.biochi.2016.12.019_bib14","doi-asserted-by":"crossref","first-page":"7473","DOI":"10.1073\/pnas.96.13.7473","article-title":"A\u00a0critical role for the peroxisome proliferator-activated receptor alpha (PPARalpha) in the cellular fasting response: the PPARalpha-null mouse as a model of fatty acid oxidation disorders","volume":"96","author":"Leone","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.biochi.2016.12.019_bib15","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.molmet.2014.02.002","article-title":"Integrated physiology and systems biology of PPARalpha","volume":"3","author":"Kersten","year":"2014","journal-title":"Mol. Metab."},{"key":"10.1016\/j.biochi.2016.12.019_bib16","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/0006-2952(90)90551-U","article-title":"The effect of beclobric acid and clofibric acid on peroxisomal beta-oxidation and peroxisome proliferation in primary cultures of rat, monkey and human hepatocytes","volume":"40","author":"Blaauboer","year":"1990","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.biochi.2016.12.019_bib17","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1124\/mol.53.1.14","article-title":"Peroxisome proliferator activated receptor-alpha expression in human liver","volume":"53","author":"Palmer","year":"1998","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.biochi.2016.12.019_bib18","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.jhep.2015.02.019","article-title":"PPARalpha gene expression correlates with severity and histological treatment response in patients with non-alcoholic steatohepatitis","volume":"63","author":"Francque","year":"2015","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.biochi.2016.12.019_bib19","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1186\/s12864-015-1969-3","article-title":"The impact of PPARalpha activation on whole genome gene expression in human precision cut liver slices","volume":"16","author":"Janssen","year":"2015","journal-title":"BMC genomics"},{"key":"10.1016\/j.biochi.2016.12.019_bib20","first-page":"14","article-title":"A\u00a0map of the PPARalpha transcription regulatory network for primary human hepatocytes","volume":"209C","author":"McMullen","year":"2013","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.biochi.2016.12.019_bib21","doi-asserted-by":"crossref","first-page":"e6796","DOI":"10.1371\/journal.pone.0006796","article-title":"Comparative analysis of gene regulation by the transcription factor PPARalpha between mouse and human","volume":"4","author":"Rakhshandehroo","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.biochi.2016.12.019_bib22","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1016\/j.bbagrm.2016.03.007","article-title":"Genomewide comparison of the inducible transcriptomes of nuclear receptors CAR, PXR and PPARalpha in primary human hepatocytes","volume":"1859","author":"Kandel","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.biochi.2016.12.019_bib23","doi-asserted-by":"crossref","first-page":"4312","DOI":"10.1073\/pnas.94.9.4312","article-title":"Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors alpha and delta","volume":"94","author":"Forman","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.biochi.2016.12.019_bib24","doi-asserted-by":"crossref","first-page":"4318","DOI":"10.1073\/pnas.94.9.4318","article-title":"Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors alpha and gamma","volume":"94","author":"Kliewer","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.biochi.2016.12.019_bib25","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1210\/mend.11.6.0007","article-title":"Fatty acids, eicosanoids, and hypolipidemic agents identified as ligands of peroxisome proliferator-activated receptors by coactivator-dependent receptor ligand assay","volume":"11","author":"Krey","year":"1997","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.biochi.2016.12.019_bib26","doi-asserted-by":"crossref","first-page":"e1681","DOI":"10.1371\/journal.pone.0001681","article-title":"Effect of synthetic dietary triglycerides: a novel research paradigm for nutrigenomics","volume":"3","author":"Sanderson","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.biochi.2016.12.019_bib27","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.cell.2009.05.036","article-title":"Identification of a physiologically relevant endogenous ligand for PPARalpha in liver","volume":"138","author":"Chakravarthy","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.biochi.2016.12.019_bib28","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jmgm.2014.04.006","article-title":"A\u00a0single amino acid change humanizes long-chain fatty acid binding and activation of mouse peroxisome proliferator-activated receptor alpha","volume":"51","author":"Oswal","year":"2014","journal-title":"J.\u00a0Mol. Graph. Model."},{"key":"10.1016\/j.biochi.2016.12.019_bib29","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1194\/jlr.M035436","article-title":"Divergence between human and murine peroxisome proliferator-activated receptor alpha ligand specificities","volume":"54","author":"Oswal","year":"2013","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.biochi.2016.12.019_bib30","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/347645a0","article-title":"Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators","volume":"347","author":"Issemann","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.biochi.2016.12.019_bib31","doi-asserted-by":"crossref","first-page":"3012","DOI":"10.1128\/MCB.15.6.3012","article-title":"Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators","volume":"15","author":"Lee","year":"1995","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.biochi.2016.12.019_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/10408444.2013.835784","article-title":"Mode of action framework analysis for receptor-mediated toxicity: the peroxisome proliferator-activated receptor alpha (PPARalpha) as a case study","volume":"44","author":"Corton","year":"2014","journal-title":"Crit. Rev. Toxicol."},{"key":"10.1016\/j.biochi.2016.12.019_bib33","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.etp.2008.09.002","article-title":"Human health risk assessment for peroxisome proliferators: more than 30 years of research, Experimental and toxicologic pathology","volume":"61","author":"Fidaleo","year":"2009","journal-title":"Off. J. Gesellschaft fur Toxikologische Pathologie"},{"key":"10.1016\/j.biochi.2016.12.019_bib34","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.tox.2007.09.030","article-title":"PPARalpha: mechanism of species differences and hepatocarcinogenesis of peroxisome proliferators","volume":"246","author":"Gonzalez","year":"2008","journal-title":"Toxicology"},{"key":"10.1016\/j.biochi.2016.12.019_bib35","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1080\/713608372","article-title":"PPARalpha agonist-induced rodent tumors: modes of action and human relevance","volume":"33","author":"Klaunig","year":"2003","journal-title":"Crit. Rev. Toxicol."},{"key":"10.1016\/j.biochi.2016.12.019_bib36","doi-asserted-by":"crossref","first-page":"2460","DOI":"10.2337\/diabetes.54.8.2460","article-title":"Therapeutic roles of peroxisome proliferator-activated receptor agonists","volume":"54","author":"Staels","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.biochi.2016.12.019_bib37","first-page":"542","article-title":"Fibrates and future PPARalpha agonists in the treatment of cardiovascular disease, Nature clinical practice","volume":"5","author":"Staels","year":"2008","journal-title":"Cardiovasc. Med."},{"key":"10.1016\/j.biochi.2016.12.019_bib38","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/BF00302723","article-title":"Fenofibrate and human liver. Lack of proliferation of peroxisomes","volume":"53","author":"Gariot","year":"1983","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.biochi.2016.12.019_bib39","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1093\/toxsci\/kfh253","article-title":"Activation of mouse and human peroxisome proliferator-activated receptors (PPARs) by phthalate monoesters","volume":"82","author":"Bility","year":"2004","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.biochi.2016.12.019_bib40","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1515\/bchm.1997.378.7.651","article-title":"PPAR alpha structure-function relationships derived from species-specific differences in responsiveness to hypolipidemic agents","volume":"378","author":"Keller","year":"1997","journal-title":"Biol. Chem."},{"key":"10.1016\/j.biochi.2016.12.019_bib41","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0960-0760(94)90089-2","article-title":"Human and rat peroxisome proliferator activated receptors (PPARs) demonstrate similar tissue distribution but different responsiveness to PPAR activators","volume":"51","author":"Mukherjee","year":"1994","journal-title":"J.\u00a0Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.biochi.2016.12.019_bib42","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1021\/jm990554g","article-title":"The PPARs: from orphan receptors to drug discovery","volume":"43","author":"Willson","year":"2000","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.biochi.2016.12.019_bib43","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.2337\/diab.46.8.1319","article-title":"Tissue distribution and quantification of the expression of mRNAs of peroxisome proliferator-activated receptors and liver X receptor-alpha in humans: no alteration in adipose tissue of obese and NIDDM patients","volume":"46","author":"Auboeuf","year":"1997","journal-title":"Diabetes"},{"key":"10.1016\/j.biochi.2016.12.019_bib44","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/j.1749-6632.1996.tb18620.x","article-title":"Peroxisome proliferator-activated receptors: structures and function","volume":"804","author":"Tugwood","year":"1996","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.biochi.2016.12.019_bib45","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1186\/s12885-015-1500-x","article-title":"The truncated splice variant of peroxisome proliferator-activated receptor alpha, PPARalpha-tr, autonomously regulates proliferative and pro-inflammatory genes","volume":"15","author":"Thomas","year":"2015","journal-title":"BMC cancer"},{"key":"10.1016\/j.biochi.2016.12.019_bib46","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1152\/physiolgenomics.00198.2006","article-title":"Genome-wide analysis of PPARalpha activation in murine small intestine","volume":"30","author":"Bunger","year":"2007","journal-title":"Physiol. Genomics"},{"key":"10.1016\/j.biochi.2016.12.019_bib47","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.cmet.2013.07.004","article-title":"DNA methylation analysis in nonalcoholic fatty liver disease suggests distinct disease-specific and remodeling signatures after bariatric surgery","volume":"18","author":"Ahrens","year":"2013","journal-title":"Cell Metab."},{"key":"10.1016\/j.biochi.2016.12.019_bib48","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.numecd.2008.06.009","article-title":"The effect of a short-term hypocaloric diet on liver gene expression and metabolic risk factors in obese women","volume":"19","author":"Hietaniemi","year":"2009","journal-title":"Nutr. Metab. Cardiovasc Dis."},{"key":"10.1016\/j.biochi.2016.12.019_bib49","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1002\/hep.26661","article-title":"Hepatic gene expression profiles differentiate presymptomatic patients with mild versus severe nonalcoholic fatty liver disease","volume":"59","author":"Moylan","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.biochi.2016.12.019_bib50","first-page":"1535","article-title":"A\u00a0truncated human peroxisome proliferator-activated receptor alpha splice variant with dominant negative activity","volume":"13","author":"Gervois","year":"1999","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.biochi.2016.12.019_bib51","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1002\/j.1460-2075.1992.tb05072.x","article-title":"The mouse peroxisome proliferator activated receptor recognizes a response element in the 5' flanking sequence of the rat acyl CoA oxidase gene","volume":"11","author":"Tugwood","year":"1992","journal-title":"Embo J."},{"key":"10.1016\/j.biochi.2016.12.019_bib52","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.2337\/db07-0156","article-title":"Genes involved in fatty acid partitioning and binding, lipolysis, monocyte\/macrophage recruitment, and inflammation are overexpressed in the human fatty liver of insulin-resistant subjects","volume":"56","author":"Westerbacka","year":"2007","journal-title":"Diabetes"},{"key":"10.1016\/j.biochi.2016.12.019_bib53","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.cyto.2012.10.007","article-title":"Tumour necrosis factor alpha down-regulates the expression of peroxisome proliferator activated receptor alpha (PPARalpha) in human hepatocarcinoma HepG2 cells by activation of NF-kappaB pathway","volume":"61","author":"Lim","year":"2013","journal-title":"Cytokine"},{"key":"10.1016\/j.biochi.2016.12.019_bib54","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1016\/j.biocel.2007.05.015","article-title":"Interleukin-6 inhibits human peroxisome proliferator activated receptor alpha gene expression via CCAAT\/enhancer-binding proteins in hepatocytes","volume":"39","author":"Chew","year":"2007","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.biochi.2016.12.019_bib55","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1002\/hep.23337","article-title":"Kupffer cells promote hepatic steatosis via interleukin-1beta-dependent suppression of peroxisome proliferator-activated receptor alpha activity","volume":"51","author":"Stienstra","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.biochi.2016.12.019_bib56","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.ymgme.2012.08.004","article-title":"Fatty liver and anti-oxidant enzyme activities along with peroxisome proliferator-activated receptors gamma and alpha expressions in the liver of Wilson's disease","volume":"107","author":"Nagasaka","year":"2012","journal-title":"Mol. Genet. Metabol."},{"key":"10.1016\/j.biochi.2016.12.019_bib57","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1053\/j.gastro.2004.11.016","article-title":"Impaired expression of the peroxisome proliferator-activated receptor alpha during hepatitis C virus infection","volume":"128","author":"Dharancy","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.biochi.2016.12.019_bib58","doi-asserted-by":"crossref","first-page":"7591","DOI":"10.3748\/wjg.v11.i48.7591","article-title":"Hepatitis C virus infection down-regulates the expression of peroxisome proliferator-activated receptor alpha and carnitine palmitoyl acyl-CoA transferase 1A","volume":"11","author":"Cheng","year":"2005","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.biochi.2016.12.019_bib59","doi-asserted-by":"crossref","first-page":"790","DOI":"10.6061\/clinics\/2015(12)05","article-title":"Hepatic peroxisome proliferator-activated receptor gamma and alpha-mRNA expression in HCV-infected adults is decreased by HIV co-infection and is also affected by ethnicity","volume":"70","author":"Shores","year":"2015","journal-title":"Clinics"},{"key":"10.1016\/j.biochi.2016.12.019_bib60","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1002\/hep.24645","article-title":"Alteration of hepatic nuclear receptor-mediated signaling pathways in hepatitis C virus patients with and without a history of alcohol drinking","volume":"54","author":"Wu","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.biochi.2016.12.019_bib61","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1074\/jbc.M115.674861","article-title":"Fatty acid oxidation in hepatoma cells infected with hepatitis C virus","volume":"291","author":"Douglas","year":"2016","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.biochi.2016.12.019_bib62","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1007\/s11095-011-0473-y","article-title":"PPARalpha is regulated by miR-21 and miR-27b in human liver","volume":"28","author":"Kida","year":"2011","journal-title":"Pharm. Res."},{"key":"10.1016\/j.biochi.2016.12.019_bib63","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1186\/s12885-015-1562-9","article-title":"Functional microRNA high throughput screening reveals miR-9 as a central regulator of liver oncogenesis by affecting the PPARA-CDH1 pathway","volume":"15","author":"Drakaki","year":"2015","journal-title":"BMC cancer"},{"key":"10.1016\/j.biochi.2016.12.019_bib64","doi-asserted-by":"crossref","first-page":"e34165","DOI":"10.1371\/journal.pone.0034165","article-title":"MicroRNA-141 represses HBV replication by targeting PPARA","volume":"7","author":"Hu","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.biochi.2016.12.019_bib65","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1530\/JME-14-0127","article-title":"Aberrant miR199a-5p\/caveolin1\/PPARalpha axis in hepatic steatosis","volume":"53","author":"Li","year":"2014","journal-title":"J.\u00a0Mol. Endocrinol."},{"key":"10.1016\/j.biochi.2016.12.019_bib66","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1210\/me.2003-0327","article-title":"The protein kinase C signaling pathway regulates a molecular switch between transactivation and transrepression activity of the peroxisome proliferator-activated receptor alpha","volume":"18","author":"Blanquart","year":"2004","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.biochi.2016.12.019_bib67","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1210\/me.2002-0120","article-title":"Bile acids induce the expression of the human peroxisome proliferator-activated receptor alpha gene via activation of the farnesoid X receptor","volume":"17","author":"Pineda Torra","year":"2003","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.biochi.2016.12.019_bib68","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1124\/mol.104.005389","article-title":"Regulation of human hepatic hydroxysteroid sulfotransferase gene expression by the peroxisome proliferator-activated receptor alpha transcription factor","volume":"67","author":"Fang","year":"2005","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.biochi.2016.12.019_bib69","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1002\/hep.26894","article-title":"Peroxisome proliferator-activated receptor alpha activates human multidrug resistance transporter 3\/ATP-binding cassette protein subfamily B4 transcription and increases rat biliary phosphatidylcholine secretion","volume":"59","author":"Ghonem","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.biochi.2016.12.019_bib70","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1124\/mol.115.100255","article-title":"CYP2C8 is a novel target of peroxisome proliferator-activated receptor alpha in human liver","volume":"89","author":"Makia","year":"2016","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.biochi.2016.12.019_bib71","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1007\/s00018-007-7006-1","article-title":"Glycogen synthase 2 is a novel target gene of peroxisome proliferator-activated receptors","volume":"64","author":"Mandard","year":"2007","journal-title":"Cell Mol. Life Sci."},{"key":"10.1016\/j.biochi.2016.12.019_bib72","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.bcp.2009.05.007","article-title":"Identification of a functional peroxisome proliferator-activated receptor (PPAR) response element (PPRE) in the human apolipoprotein A-IV gene","volume":"78","author":"Nagasawa","year":"2009","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.biochi.2016.12.019_bib73","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.jhep.2006.11.019","article-title":"The Interleukin-1 receptor antagonist is a direct target gene of PPARalpha in liver","volume":"46","author":"Stienstra","year":"2007","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.biochi.2016.12.019_bib74","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0041-008X(03)00015-2","article-title":"Comprehensive analysis of gene expression in rat and human hepatoma cells exposed to the peroxisome proliferator WY14,643","volume":"188","author":"Vanden Heuvel","year":"2003","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.biochi.2016.12.019_bib75","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s11095-010-0294-4","article-title":"Human NPC1L1 expression is positively regulated by PPARalpha","volume":"28","author":"Iwayanagi","year":"2011","journal-title":"Pharm. Res."},{"key":"10.1016\/j.biochi.2016.12.019_bib76","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1074\/jbc.M112.437525","article-title":"Peroxisome proliferator-activated receptor alpha positively regulates complement C3 expression but inhibits tumor necrosis factor alpha-mediated activation of C3 gene in mammalian hepatic-derived cells","volume":"288","author":"Mogilenko","year":"2013","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.biochi.2016.12.019_bib77","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1194\/jlr.M300279-JLR200","article-title":"PPARalpha controls the intracellular coenzyme A concentration via regulation of PANK1alpha gene expression","volume":"45","author":"Ramaswamy","year":"2004","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.biochi.2016.12.019_bib78","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.bbrc.2009.09.018","article-title":"Regulation of the human SLC25A20 expression by peroxisome proliferator-activated receptor alpha in human hepatoblastoma cells","volume":"389","author":"Tachibana","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.biochi.2016.12.019_bib79","doi-asserted-by":"crossref","first-page":"27950","DOI":"10.1074\/jbc.M100258200","article-title":"Identification of peroxisome proliferator-responsive human genes by elevated expression of the peroxisome proliferator-activated receptor alpha in HepG2 cells","volume":"276","author":"Hsu","year":"2001","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.biochi.2016.12.019_bib80","doi-asserted-by":"crossref","first-page":"31521","DOI":"10.1074\/jbc.M103306200","article-title":"Differential gene regulation in human versus rodent hepatocytes by peroxisome proliferator-activated receptor (PPAR) alpha. PPAR alpha fails to induce peroxisome proliferation-associated genes in human cells independently of the level of receptor expresson","volume":"276","author":"Lawrence","year":"2001","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.biochi.2016.12.019_bib81","doi-asserted-by":"crossref","first-page":"15655","DOI":"10.1073\/pnas.232137699","article-title":"Infection of a human hepatoma cell line by hepatitis B virus","volume":"99","author":"Gripon","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.biochi.2016.12.019_bib82","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.taap.2014.02.001","article-title":"PPAR agonists reduce steatosis in oleic acid-overloaded HepaRG cells","volume":"276","author":"Rogue","year":"2014","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.biochi.2016.12.019_bib83","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1016\/j.bcp.2007.08.020","article-title":"Highly sensitive upregulation of apolipoprotein A-IV by peroxisome proliferator-activated receptor alpha (PPARalpha) agonist in human hepatoma cells","volume":"74","author":"Nagasawa","year":"2007","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.biochi.2016.12.019_bib84","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.tiv.2014.12.019","article-title":"Transcriptomic analysis of untreated and drug-treated differentiated HepaRG cells over a 2-week period","volume":"30","author":"Savary","year":"2015","journal-title":"Toxicol. Vitro Int. J. Publ. Assoc. BIBRA"},{"key":"10.1016\/j.biochi.2016.12.019_bib85","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1074\/jbc.271.4.2147","article-title":"Identification of a peroxisome proliferator-responsive element upstream of the human peroxisomal fatty acyl coenzyme A oxidase gene","volume":"271","author":"Varanasi","year":"1996","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.biochi.2016.12.019_bib86","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.bbrc.2007.06.068","article-title":"PPARalpha is a key regulator of hepatic FGF21","volume":"360","author":"Lundasen","year":"2007","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.biochi.2016.12.019_bib87","doi-asserted-by":"crossref","first-page":"17982","DOI":"10.1074\/jbc.M212191200","article-title":"Apolipoprotein A5, a crucial determinant of plasma triglyceride levels, is highly responsive to peroxisome proliferator-activated receptor alpha activators","volume":"278","author":"Vu-Dac","year":"2003","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.biochi.2016.12.019_bib88","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1172\/JCI118118","article-title":"Fibrates increase human apolipoprotein A-II expression through activation of the peroxisome proliferator-activated receptor","volume":"96","author":"Vu-Dac","year":"1995","journal-title":"J.\u00a0Clin. Investig."},{"key":"10.1016\/j.biochi.2016.12.019_bib89","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1124\/mol.112.082503","article-title":"Direct transcriptional regulation of human hepatic cytochrome P450 3A4 (CYP3A4) by peroxisome proliferator-activated receptor alpha (PPARalpha)","volume":"83","author":"Thomas","year":"2013","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.biochi.2016.12.019_bib90","doi-asserted-by":"crossref","first-page":"E595","DOI":"10.1152\/ajpendo.00299.2011","article-title":"Plasma mannose-binding lectin is stimulated by PPARalpha in humans","volume":"302","author":"Rakhshandehroo","year":"2012","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.biochi.2016.12.019_bib91","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1093\/jb\/mvt050","article-title":"Human mannose-binding lectin 2 is directly regulated by peroxisome proliferator-activated receptors via a peroxisome proliferator responsive element","volume":"154","author":"Tachibana","year":"2013","journal-title":"J.\u00a0Biochem."},{"key":"10.1016\/j.biochi.2016.12.019_bib92","doi-asserted-by":"crossref","first-page":"32852","DOI":"10.1074\/jbc.M305361200","article-title":"Peroxisome proliferator-activated receptor alpha induces hepatic expression of the human bile acid glucuronidating UDP-glucuronosyltransferase 2B4 enzyme","volume":"278","author":"Barbier","year":"2003","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.biochi.2016.12.019_bib93","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1124\/dmd.106.013243","article-title":"Expression of the human UGT1 locus in transgenic mice by 4-chloro-6-(2,3-xylidino)-2-pyrimidinylthioacetic acid (WY-14643) and implications on drug metabolism through peroxisome proliferator-activated receptor alpha activation","volume":"35","author":"Senekeo-Effenberger","year":"2007","journal-title":"Drug Metabol. Dispos. Biol. Fate Chem."},{"key":"10.1016\/j.biochi.2016.12.019_bib94","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1002\/hep.21362","article-title":"Human UDP-glucuronosyltransferase (UGT)1A3 enzyme conjugates chenodeoxycholic acid in the liver","volume":"44","author":"Trottier","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.biochi.2016.12.019_bib95","doi-asserted-by":"crossref","first-page":"33471","DOI":"10.1074\/jbc.M102839200","article-title":"Negative regulation of human fibrinogen gene expression by peroxisome proliferator-activated receptor alpha agonists via inhibition of CCAAT box\/enhancer-binding protein beta","volume":"276","author":"Gervois","year":"2001","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.biochi.2016.12.019_bib96","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1182\/blood-2002-06-1762","article-title":"Fibrates down-regulate IL-1-stimulated C-reactive protein gene expression in hepatocytes by reducing nuclear p50-NFkappa B-C\/EBP-beta complex formation","volume":"101","author":"Kleemann","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.biochi.2016.12.019_bib97","doi-asserted-by":"crossref","first-page":"3215","DOI":"10.1210\/en.2007-1339","article-title":"Systemic and distal repercussions of liver-specific peroxisome proliferator-activated receptor-alpha control of the acute-phase response","volume":"149","author":"Mansouri","year":"2008","journal-title":"Endocrinology"},{"key":"10.1016\/j.biochi.2016.12.019_bib98","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1096\/fj.01-0147com","article-title":"The peroxisome proliferator-activated receptor alpha regulates amino acid metabolism","volume":"15","author":"Kersten","year":"2001","journal-title":"Faseb J."},{"key":"10.1016\/j.biochi.2016.12.019_bib99","doi-asserted-by":"crossref","first-page":"3849","DOI":"10.1158\/0008-5472.CAN-04-0322","article-title":"Diminished hepatocellular proliferation in mice humanized for the nuclear receptor peroxisome proliferator-activated receptor alpha","volume":"64","author":"Cheung","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.biochi.2016.12.019_bib100","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1093\/toxsci\/kfm206","article-title":"The PPAR alpha-humanized mouse: a model to investigate species differences in liver toxicity mediated by PPAR alpha","volume":"101","author":"Yang","year":"2008","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.biochi.2016.12.019_bib101","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1093\/toxsci\/kfp077","article-title":"Differential hepatic effects of perfluorobutyrate mediated by mouse and human PPAR-alpha","volume":"110","author":"Foreman","year":"2009","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.biochi.2016.12.019_bib102","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1093\/carcin\/bgi329","article-title":"Differential susceptibility of mice humanized for peroxisome proliferator-activated receptor alpha to Wy-14,643-induced liver tumorigenesis","volume":"27","author":"Morimura","year":"2006","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.biochi.2016.12.019_bib103","doi-asserted-by":"crossref","first-page":"579","DOI":"10.33549\/physiolres.931058","article-title":"Influence of PPAR-alpha agonist fenofibrate on insulin sensitivity and selected adipose tissue-derived hormones in obese women with type 2 diabetes","volume":"56","author":"Anderlova","year":"2007","journal-title":"Physiol. Res."},{"key":"10.1016\/j.biochi.2016.12.019_bib104","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/j.numecd.2010.12.010","article-title":"Comparison of the effects of n-3 long chain polyunsaturated fatty acids and fenofibrate on markers of inflammation and vascular function, and on the serum lipoprotein profile in overweight and obese subjects","volume":"22","author":"Bragt","year":"2011","journal-title":"Nutr. Metab. Cardiovasc Dis."},{"key":"10.1016\/j.biochi.2016.12.019_bib105","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1067\/mcp.2002.128605","article-title":"Fibrate treatment does not modify the expression of acyl coenzyme A oxidase in human liver","volume":"72","author":"Roglans","year":"2002","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.biochi.2016.12.019_bib106","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1161\/01.ATV.0000154140.73570.00","article-title":"Regulation of human apoA-I by gemfibrozil and fenofibrate through selective peroxisome proliferator-activated receptor alpha modulation","volume":"25","author":"Duez","year":"2005","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.biochi.2016.12.019_bib107","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1172\/JCI118687","article-title":"Opposite regulation of human versus mouse apolipoprotein A-I by fibrates in human apolipoprotein A-I transgenic mice","volume":"97","author":"Berthou","year":"1996","journal-title":"J.\u00a0Clin. Investig."},{"key":"10.1016\/j.biochi.2016.12.019_bib108","doi-asserted-by":"crossref","first-page":"27307","DOI":"10.1074\/jbc.272.43.27307","article-title":"Alterations in lipoprotein metabolism in peroxisome proliferator-activated receptor alpha-deficient mice","volume":"272","author":"Peters","year":"1997","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.biochi.2016.12.019_bib109","doi-asserted-by":"crossref","first-page":"26839","DOI":"10.1155\/2007\/26839","article-title":"Comprehensive analysis of PPARalpha-dependent regulation of hepatic lipid metabolism by expression profiling","volume":"2007","author":"Rakhshandehroo","year":"2007","journal-title":"PPAR Res."},{"key":"10.1016\/j.biochi.2016.12.019_bib110","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1161\/ATVBAHA.108.182147","article-title":"Caloric restriction and exercise increase plasma ANGPTL4 levels in humans via elevated free fatty acids","volume":"29","author":"Kersten","year":"2009","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.biochi.2016.12.019_bib111","doi-asserted-by":"crossref","first-page":"16154","DOI":"10.1074\/jbc.M400346200","article-title":"Global suppression of IL-6-induced acute phase response gene expression after chronic in\u00a0vivo treatment with the peroxisome proliferator-activated receptor-alpha activator fenofibrate","volume":"279","author":"Gervois","year":"2004","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.biochi.2016.12.019_bib112","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1097\/MOL.0b013e3282f64542","article-title":"Single gene contributions: genetic variants of peroxisome proliferator-activated receptor (isoforms alpha, beta\/delta and gamma) and mechanisms of dyslipidemias","volume":"19","author":"Yong","year":"2008","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.biochi.2016.12.019_bib113","doi-asserted-by":"crossref","first-page":"2923","DOI":"10.2337\/dc12-2012","article-title":"Dual peroxisome proliferator-activated receptor alpha\/delta agonist GFT505 improves hepatic and peripheral insulin sensitivity in abdominally obese subjects","volume":"36","author":"Cariou","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.biochi.2016.12.019_bib114","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1002\/hep.27744","article-title":"Fibrates and cholestasis","volume":"62","author":"Ghonem","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.biochi.2016.12.019_bib115","first-page":"160","article-title":"MADMAX - management and analysis database for multiple \u223comics experiments","volume":"8","author":"Lin","year":"2011","journal-title":"J.\u00a0Integr. Bioinforma."}],"container-title":["Biochimie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300908416303613?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300908416303613?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,21]],"date-time":"2023-08-21T12:33:10Z","timestamp":1692621190000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0300908416303613"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":115,"alternative-id":["S0300908416303613"],"URL":"https:\/\/doi.org\/10.1016\/j.biochi.2016.12.019","relation":{},"ISSN":["0300-9084"],"issn-type":[{"value":"0300-9084","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role and regulation of the peroxisome proliferator activated receptor alpha in human liver","name":"articletitle","label":"Article Title"},{"value":"Biochimie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biochi.2016.12.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. and Soci\u00e9t\u00e9 Fran\u00e7aise de Biochimie et Biologie Mol\u00e9culaire (SFBBM). All rights reserved.","name":"copyright","label":"Copyright"}]}}